All Type of News
Pharmaceutical firms advised to go global
Korean pharmaceutical companies, which traditionally have depended on the local market, should turn their eyes on the overseas market next year, an industry expert said.
“The Korean pharmaceutical makers are in a s...
Reform required to ensure financial stability
The National Health Insurance Corp. (NHIC)’s health-related committee claimed that a cigarette price hike would be the most effective policy tool to deter smoking and raise additional funds for its health insurance bu...
MSD Korea fined 50 million won for illegal ads
The Korea Food and Drug Administration said Wednesday that it has fined 50 million won on MSD Korea for illegal advertisements of Singulair tablets, prescription drug, towards the general public in hospitals using a p...
Keunwha Pharm order to suspend drug manufacturing business
The government punished Keunwha Pharmaceutical Co. for illegal rebate activities on Thursday.
The Korea Food and Drug Administration ordered Keunwha Pharm to stop the manufacture of some drugs for three months.
...
Fiercer battle to be seen in generic antihypertensive drug market
With many global makers' blockbuster products coming off patent, the race for the generic antihypertensive drug market is set to be in full force next year.
The drug recently at the center of attention is the best-...
Soaring profits in web drug service
A pharmaceutical company unveiled its revamped online site several years ago, with the aim of becoming the leading drug online shopping mall and currently, generates 16 billion won annually.
The company’s main stra...
Green Cross wins big deal with U.S. firm
Green Cross Corp. said Wednesday that it has signed an memorandum of understanding (MOU) with the U.S. based ASD Healthcare, an affiliated company of the healthcare giant group Amerisourcebergen to supply Iviglobulin ...
Handok, Bayer Korea to join forces in contrast agent
Handok Pharmaceutical and Bayer Korea said on December 15 they have agreed to join hands to co-market iopromide Inj.
Both companies will co-promote iopromide contrast agent under the different brandnames - Ulltravi...
Hanmi signs deal to transfer entecavir synthesis technology to Hwail
Hanmi Pharmaceutical Co. signed Wednesday a license-out agreement with Hwail Pharmaceutical Co., a local pharmaceutical bulk maker, to transfer its new synthesis technology of entecavir.
Hanmi officials said that, ...
KRPIA abides by revised medical law
The Korean Research-based Pharmaceutical Industry Association (KRPIA) said it will strictly observe a revised law that punishes doctors for shady deals with drug makers.
“We will launch a series of resolutions prom...
